Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2020 2
2021 8
2022 8
2023 18
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss: A Systematic Review.
Drake L, Reyes-Hadsall S, Martinez J, Heinrich C, Huang K, Mostaghimi A. Drake L, et al. JAMA Dermatol. 2023 Jan 1;159(1):79-86. doi: 10.1001/jamadermatol.2022.4867. JAMA Dermatol. 2023. PMID: 36449274
Studies of nutritional interventions with the highest-quality evidence showed the potential benefit of Viviscal, Nourkrin, Nutrafol, Lamdapil, Pantogar, capsaicin and isoflavone, omegas 3 and 6 with antioxidants, apple nutraceutical, total glucosides of paeony and compound …
Studies of nutritional interventions with the highest-quality evidence showed the potential benefit of Viviscal, Nourkrin, Nutrafol, …
A Six-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Women With Self-Perceived Thinning Hair.
Ablon G, Kogan S. Ablon G, et al. J Drugs Dermatol. 2018 May 1;17(5):558-565. J Drugs Dermatol. 2018. PMID: 29742189 Clinical Trial.
The objective of this 6-month randomized, double-blind, placebo-controlled study was to assess the ability of this oral supplement (Nutrafol Women's Capsules) to strengthen and promote the growth of hair in adult women with self-perceived thinning. ...
The objective of this 6-month randomized, double-blind, placebo-controlled study was to assess the ability of this oral supplement (Nutra
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis.
Feldman PR, Gentile P, Piwko C, Motswaledi HM, Gorun S, Pesachov J, Markel M, Silver MI, Brenkel M, Feldman OJ, Kamen CL, Uleryk E, Guevara-Aguirre J, Fiebig KM. Feldman PR, et al. Front Med (Lausanne). 2023 Jan 23;9:998623. doi: 10.3389/fmed.2022.998623. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36755885 Free PMC article.
Eligible treatments included ALRV5XR, Dutasteride 0.5 mg/day, Finasteride 1 mg/day, low-level laser comb treatment (LLLT), Minoxidil 2% and 5%, Nutrafol, and Viviscal. At 24 weeks, the B-NMA regrowth efficacy in TH/cm(2) and significance ((**)) in women were ALRV5XR: 30.09 …
Eligible treatments included ALRV5XR, Dutasteride 0.5 mg/day, Finasteride 1 mg/day, low-level laser comb treatment (LLLT), Minoxidil 2% and …
Nutraceuticals.
Ablon G. Ablon G. Dermatol Clin. 2021 Jul;39(3):417-427. doi: 10.1016/j.det.2021.03.006. Epub 2021 May 12. Dermatol Clin. 2021. PMID: 34053595 Review.
A Randomized, Double-Blind, Placebo-Controlled Study of a Nutraceutical Supplement for Promoting Hair Growth in Perimenopausal, Menopausal, and Postmenopausal Women With Thinning Hair.
Ablon G, Kogan S. Ablon G, et al. J Drugs Dermatol. 2021 Jan 1;20(1):55-61. doi: 10.36849/JDD.5701. J Drugs Dermatol. 2021. PMID: 33400421 Clinical Trial.
A novel nutraceutical supplement has been specifically formulated with phytoactives to improve hair growth and quality in menopausal women (Nutrafol® Women’s Balance Capsules). The objective of this 6-month, randomized, double-blind, placebo-controlled st …
A novel nutraceutical supplement has been specifically formulated with phytoactives to improve hair growth and quality in menopausal women ( …
Nutraceuticals for Androgenetic Alopecia.
Ring C, Heitmiller K, Correia E, Gabriel Z, Saedi N. Ring C, et al. J Clin Aesthet Dermatol. 2022 Mar;15(3):26-29. J Clin Aesthet Dermatol. 2022. PMID: 35342503 Free PMC article. Review.
METHODS: This article reviews the currently available literature on the nutraceuticals Nutrafol() and Viviscal() for hair growth and describes and evaluates the results observed. ...
METHODS: This article reviews the currently available literature on the nutraceuticals Nutrafol() and Viviscal() for hair growth and …
Development of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort.
King BA, Mesinkovska NA, Craiglow B, Kindred C, Ko J, McMichael A, Shapiro J, Goh C, Mirmirani P, Tosti A, Hordinsky M, Huang KP, Castelo-Soccio L, Bergfeld W, Paller AS, Mackay-Wiggan J, Glashofer M, Aguh C, Piliang M, Yazdan P, Lo Sicco K, Cassella JV, Koenigsberg J, Ahluwalia G, Ghorayeb E, Fakharzadeh S, Napatalung L, Gandhi K, DeLozier AM, Nunes FP, Senna MM. King BA, et al. J Am Acad Dermatol. 2022 Feb;86(2):359-364. doi: 10.1016/j.jaad.2021.08.043. Epub 2021 Aug 30. J Am Acad Dermatol. 2022. PMID: 34474079 Free article.
Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study.
King B, Ko J, Forman S, Ohyama M, Mesinkovska N, Yu G, McCollam J, Gamalo M, Janes J, Edson-Heredia E, Holzwarth K, Dutronc Y. King B, et al. J Am Acad Dermatol. 2021 Oct;85(4):847-853. doi: 10.1016/j.jaad.2021.05.050. Epub 2021 Jun 16. J Am Acad Dermatol. 2021. PMID: 34090959 Free article. Clinical Trial.
38 results